Helen YeonJu Chung: Reflections from My 1st World Federation of Hemophilia Congress
Helen YeonJu Chung, Senior Manager in Regional Marketing at Sysmex Asia Pacific, shared on LinkedIn:
”My first time attending the World Federation of Hemophilia Congress (WFH) – and it left a strong impression.
What stood out most wasn’t just the science, but the people.
Clinicians, lab professionals, patients, and advocates from all over the world, all in one place.
What I hadn’t seen before was patients attending scientific sessions – fully engaged, asking questions, and eager to learn.
That level of curiosity and ownership was powerful to witness.
You could feel a shared intent to turn knowledge into better haemophilia management and everyday quality of life.
It also reinforced something important for me: in diagnostics, we go beyond delivering results.
We are part of a broader ecosystem alongside pharma and healthcare providers, contributing to better monitoring, decisions, and peace of mind for patients.
Grateful to have been part of this experience with my knowledgeable Sysmex colleagues and KOLs – still a lot to learn, but moments like this remind me why it matters.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 16:42Kate Grushetzkaya: The Essential Flow Cytometry Checklist – 6 Steps to Better Data
-
Sep 20, 2026, 16:32New Episode of The Hematologist Podcast – ASH
-
Sep 20, 2026, 16:26Thomas Schinecker: A New Era for Health Innovation – Inside the Roche Genentech Innovation Center
-
Sep 20, 2026, 16:19Astha Srivastava: The Missing Megakaryocytes in Amegakaryocytic Thrombocytopenia
-
Sep 20, 2026, 16:19Heghine Khachatryan: An Elegant Example of Precision Thrombolysis – Targeting the Scaffold of Microvascular Thrombosis
-
Sep 20, 2026, 16:01Mohamed Ismail: Managing Extensive Iliofemoral and Inferior Vena Cava DVT
-
Sep 20, 2026, 15:58Can αIIbβ3 Receptor Play a Role in Platelet Production – Glanzmann’s Research Foundation
-
Sep 20, 2026, 15:46Alexsander Santiago: Evaluating Clinical Harm from Missing versus Overdiagnosing HIT
-
Sep 20, 2026, 15:28Nico Gagelmann: iMTSS to Dissect the Drivers of Post-Transplant Outcomes